Contents

Current Cancer Drug Targets, Volume 3 - Number 1

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation

, 3(1): 1 - 19

R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden


DOI: 10.2174/1568009033333754




Mechanisms Controlling Sensitivity to Platinum Complexes: Role of p53 and DNA Mismatch Repair

, 3(1): 21 - 29

S. Manic, L. Gatti, N. Carenini, G. Fumagalli, F. Zunino and P. Perego


DOI: 10.2174/1568009033333727




Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase

, 3(1): 31 - 40

Alla Danilkovitch-Miagkova


DOI: 10.2174/1568009033333745




Molecular Targets of the Oncogenic Transcription Factor Jun

, 3(1): 41 - 55

M. Hartl, A. G. Bader and K. Bister


DOI: 10.2174/1568009033333781




The Prodigiosins: A New Family of Anticancer Drugs

, 3(1): 57 - 65

Beatriz Montaner and Ricardo Pérez-Tomás


DOI: 10.2174/1568009033333772




Garlic [Allium sativum]: A Review of its Potential Use as an Anti-Cancer Agent

, 3(1): 67 - 81

Martha Thomson and Muslim Ali


DOI: 10.2174/1568009033333736




Author Index To Volume 2

, 3(1): 83

Bentham Science Publishers


DOI: 10.2174/1568009033333600




subject Index To Volume 2

, 3(1): 85 - 87

Bentham Science Publishers


DOI: 10.2174/1568009033333763




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science